Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry

Casanova, MJ; Chaparro, M; Minguez, M; Ricart, E; Taxonera, C; Garcia-Lopez, S; Guardiola, J; Lopez-San Roman, A; Iglesias, E; Beltran, B; Sicilia, B; Vera, MI; Hinojosa, J; Riestra, S; Domenech, E; Calvet, X; Perez-Calle, JL; Martin-Arranz, MD; Aldeguer, X; Rivero, M; Monfort, D; Barrio, J; Esteve, M; Marquez, L; Lorente, R; Garcia-Planella, E; de Castro, L; Bermejo, F; Merino, O; Rodriguez-Perez, A; Martinez-Montiel, P; Van Domselaar, M; Alcain, G; Dominguez-Cajal, M; Munoz, C; Gomollon, F; Fernandez-Salazar, L; Garcia-Sepulcre, MF; Rodriguez-Lago, I; Gutierrez, A; Arguelles-Arias, F; Rodriguez, C; Rodriguez, GE; Bujanda, L; Llao, J; Varela, P; Ramos, L; Huguet, JM; Almela, P; Romero, P; Navarro-Llavat, M; Abad, A; Ramirez-de la Piscina, P; Lucendo, AJ; Sese, E; Madrigal, RE; Charro, M; Garcia-Herola, A; Pajares, R; Khorrami, S; Gisbert, JP – 2020